{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T18:47:43Z","timestamp":1790448463244,"version":"4.1.0"},"reference-count":49,"publisher":"Bentham Science Publishers Ltd.","issue":"4","license":[{"start":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T00:00:00Z","timestamp":1691020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/legalcode"}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CRR"],"published-print":{"date-parts":[[2023,8,3]]},"abstract":"<jats:sec>\n<jats:title>Introduction:<\/jats:title>\n<jats:p>Rheumatic diseases are a spectrum of autoimmune or inflammatory diseases that cause damage to the musculoskeletal system as well as vital organs, such as the heart, lungs, kidneys, and central nervous system.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>The study of rheumatic disease has made great pro-gress in the understanding and management of these conditions in the last few decades using dis-ease-modifying antirheumatic drugs and synthesized biological immunomodulating therapies. How-ever, one potential treatment that has not been well investigated in rheumatic disease is platelet-rich plasma (PRP). PRP is proposed to facilitate the healing of injured tendons and ligaments through a variety of mechanisms, including mitogenesis, angiogenesis and macrophage activation via cyto-kine release, although its exact mechanism is unclear.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Result::<\/jats:title>\n<jats:p>There has been a great deal of work in determining the exact preparation method and composition of PRP for regenerative purposes in or-thopedic surgery, sports medicine, dentistry, cardiac surgery, pediatric surgery, gynecology, urolo-gy, plastic surgery, ophthalmology, and dermatology. Despite this, there is a paucity of research on the impact of PRP on rheumatic disease<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion::<\/jats:title>\n<jats:p>This study aims to summarize and evaluate the current research concerning the use of PRP in rheumatic disease.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573397119666230420112017","type":"journal-article","created":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T12:57:01Z","timestamp":1681995421000},"page":"400-407","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Current State of Platelet-rich Plasma in the Treatment of Rheumatic\nDisease: A Retrospective Review of the Literature"],"prefix":"10.2174","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9732-9771","authenticated-orcid":true,"given":"Adam","family":"Jacobs","sequence":"first","affiliation":[{"name":"Mount Sinai Medical Center, Miami Beach, FL, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0786-8035","authenticated-orcid":true,"given":"Omar","family":"Elghawy","sequence":"additional","affiliation":[{"name":"University of Virginia School of Medicine, Charlottesville,\nVA, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4709-5441","authenticated-orcid":true,"given":"Diego","family":"Lugo Baruqui","sequence":"additional","affiliation":[{"name":"Mount Sinai Medical Center, Miami Beach, FL, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3139-372X","authenticated-orcid":true,"given":"Ahmed","family":"Aly Elghawy","sequence":"additional","affiliation":[{"name":"Department of Rheumatologic and Immunologic Disease, Cleveland Clinic, Cleveland, OH, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1002\/art.39692","volume":"68","author":"Hootman J.M.","year":"2016","unstructured":"Hootman J.M.; Helmick C.G.; Barbour K.E.; Theis K.A.; Boring M.A.; Updated projected prevalence of self-reported doctor-diagnosed arthritis and arthritis-attributable activity limitation among US adults, 2015-2040. Arthritis Rheumatol 2016,68(7),1582-1587","journal-title":"Arthritis Rheumatol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.15585\/mmwr.mm7040a2","volume":"70","author":"Theis K.A.","year":"2021","unstructured":"Theis K.A.; Murphy L.B.; Guglielmo D.; Prevalence of arthritis and arthritis-attributable activity limitation \u2014 United States, 2016\u20132018. MMWR Morb Mortal Wkly Rep 2021,70(40),1401-1407","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref=3","first-page":"e413","volume":"164","author":"Conti F.","year":"2013","unstructured":"Conti F.; Ceccarelli F.; Massaro L.; Biological therapies in rheumatic diseases. Clin Ter 2013,164(5),e413-e428","journal-title":"Clin Ter"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/nrrheum.2014.6","volume":"10","author":"Deane K.D.","year":"2014","unstructured":"Deane K.D.; El-Gabalawy H.; Pathogenesis and prevention of rheumatic disease: Focus on preclinical RA and SLE. Nat Rev Rheumatol 2014,10(4),212-228","journal-title":"Nat Rev Rheumatol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1001\/jama.2018.13103","volume":"320","author":"Aletaha D.","year":"2018","unstructured":"Aletaha D.; Smolen J.S.; Diagnosis and management of rheumatoid arthritis. JAMA 2018,320(13),1360-1372","journal-title":"JAMA"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1186\/s12891-016-1289-z","volume":"17","author":"Voshaar M.","year":"2016","unstructured":"Voshaar M.; Vriezekolk J.; van Dulmen S.; van den Bemt B.; van de Laar M.; Barriers and facilitators to disease-modifying antirheumatic drug use in patients with inflammatory rheumatic diseases: A qualitative theory-based study. BMC Musculoskelet Disord 2016,17(1),442","journal-title":"BMC Musculoskelet Disord"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1136\/annrheumdis-2021-220202","volume":"80","author":"Vallejo-Yag\u00fce E.","year":"2021","unstructured":"Vallejo-Yag\u00fce E.; Keystone E.C.; Kandhasamy S.; Micheroli R.; Finckh A.; Burden A.M.; Primary and secondary non-response: In need of operational definitions in observational studies. Ann Rheum Dis 2021,80(8),961-964","journal-title":"Ann Rheum Dis"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.arthro.2016.09.024","volume":"33","author":"Dai W.L.","year":"2017","unstructured":"Dai W.L.; Zhou A.G.; Zhang H.; Zhang J.; Efficacy of platelet-rich plasma in the treatment of knee osteoarthritis: A meta-analysis of randomized controlled trials. Arthroscopy 2017,33(3),659-670.e1","journal-title":"Arthroscopy"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"7794","DOI":"10.3390\/ijms21207794","volume":"21","author":"Everts P.","year":"2020","unstructured":"Everts P.; Onishi K.; Jayaram P.; Lana J.F.; Mautner K.; Platelet-rich plasma: New performance understandings and therapeutic considerations in 2020. Int J Mol Sci 2020,21(20),7794","journal-title":"Int J Mol Sci"},{"key":"ref=10","doi-asserted-by":"publisher","DOI":"10.23736\/S0026-4806.21.07343-2","author":"Wang Y.","year":"2021","unstructured":"Wang Y.; Zhu J.; He T.; Shao S.; Wei Z.; Mechanism of platelet rich plasma components and stem cell therapy in inhibiting cartilage inflammatory factor expression in patients with knee osteoarthritis. Minerva Med 2021","journal-title":"Minerva Med"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s10238-017-0449-2","volume":"17","author":"Tong S.","year":"2017","unstructured":"Tong S.; Liu J.; Zhang C.; Platelet-rich plasma inhibits inflammatory factors and represses rheumatoid fibroblast-like synoviocytes in rheumatoid arthritis. Clin Exp Med 2017,17(4),441-449","journal-title":"Clin Exp Med"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2147\/VMRR.S286913","volume":"12","author":"King W.","year":"2021","unstructured":"King W.; Cawood K.; Bookmiller M.; The use of autologous protein solution (Pro-Stride\u00ae) and leukocyte-rich platelet-rich plasma (Restigen\u00ae) in canine medicine. Vet Med 2021,12,53-65","journal-title":"Vet Med"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1292\/jvms.20-0730","volume":"83","author":"Okamoto-Okubo C.E.","year":"2021","unstructured":"Okamoto-Okubo C.E.; Cassu R.N.; Joaquim J.G.F.; Chronic pain and gait analysis in dogs with degenerative hip joint disease treated with repeated intra-articular injections of platelet-rich plasma or allogeneic adipose-derived stem cells. J Vet Med Sci 2021,83(5),881-888","journal-title":"J Vet Med Sci"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1186\/s13018-021-02792-w","volume":"16","author":"Liu H.","year":"2021","unstructured":"Liu H.; Rui Y.; Liu J.; Gao F.; Jin Y.; Hyaluronic acid hydrogel encapsulated BMP-14-modified ADSCs accelerate cartilage defect repair in rabbits. J Orthop Surg Res 2021,16(1),657","journal-title":"J Orthop Surg Res"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"101646","DOI":"10.1016\/j.tice.2021.101646","volume":"73","author":"Yang J.","year":"2021","unstructured":"Yang J.; Guo A.; Li Q.; Wu J.; Platelet-rich plasma attenuates interleukin-1\u03b2-induced apoptosis and inflammation in chondrocytes through targeting hypoxia-inducible factor-2\u03b1. Tissue Cell 2021,73,101646","journal-title":"Tissue Cell"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.3390\/biomedicines9111726","volume":"9","author":"Pel\u00e1ez P.","year":"2021","unstructured":"Pel\u00e1ez P.; Dami\u00e1 E.; Torres-Torrillas M.; Cell and cell free therapies in osteoarthritis. Biomedicines 2021,9(11),1726","journal-title":"Biomedicines"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"3635465211061606","DOI":"10.1177\/03635465211061606","author":"Boivin J.","year":"2021","unstructured":"Boivin J.; Tolsma R.; Awad P.; Kenter K.; Li Y.; The biological use of platelet-rich plasma in skeletal muscle injury and repair. Am J Sports Med 2021,3635465211061606","journal-title":"Am J Sports Med"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1159\/000477353","volume":"4","author":"Alves R.","year":"2018","unstructured":"Alves R.; Grimalt R.; A review of platelet-rich plasma: history, biology, mechanism of action, and classification. Skin Appendage Disord 2018,4(1),18-24","journal-title":"Skin Appendage Disord"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.arthro.2014.02.020","volume":"30","author":"Magalon J.","year":"2014","unstructured":"Magalon J.; Bausset O.; Serratrice N.; Characterization and comparison of 5 platelet-rich plasma preparations in a single-donor model. Arthroscopy 2014,30(5),629-638","journal-title":"Arthroscopy"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3390\/gels7040222","volume":"7","author":"Palco M.","year":"2021","unstructured":"Palco M.; Rizzo P.; Basile G.C.; Short- and midterm comparison of platelet-rich plasma with hyaluronic acid versus leucocyte and platelet-rich plasma on pain and function to treat hip osteoarthritis. a retrospective study. Gels 2021,7(4),222","journal-title":"Gels"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s10067-020-05241-x","volume":"40","author":"Medina-Porqueres I.","year":"2021","unstructured":"Medina-Porqueres I.; Ortega-Castillo M.; Muriel-Garcia A.; Effectiveness of platelet-rich plasma in the management of hip osteoarthritis: A systematic review and meta-analysis. Clin Rheumatol 2021,40(1),53-64","journal-title":"Clin Rheumatol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.arthro.2020.10.013","volume":"37","author":"Xu Z.","year":"2021","unstructured":"Xu Z.; He Z.; Shu L.; Li X.; Ma M.; Ye C.; Intra-articular platelet-rich plasma combined with hyaluronic acid injection for knee osteoarthritis is superior to platelet-rich plasma or hyaluronic acid alone in inhibiting inflammation and improving pain and function. Arthroscopy 2021,37(3),903-915","journal-title":"Arthroscopy"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1136\/bjsports-2020-102179","volume":"55","author":"Gazendam A.","year":"2021","unstructured":"Gazendam A.; Ekhtiari S.; Bozzo A.; Phillips M.; Bhandari M.; Intra-articular saline injection is as effective as corticosteroids, platelet-rich plasma and hyaluronic acid for hip osteoarthritis pain: a systematic review and network meta-analysis of randomised controlled trials. Br J Sports Med 2021,55(5),256-261","journal-title":"Br J Sports Med"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1001\/jama.2021.16602","volume":"326","author":"Paget L.D.A.","year":"2021","unstructured":"Paget L.D.A.; Reurink G.; de Vos R.J.; Effect of platelet-rich plasma injections vs placebo on ankle symptoms and function in patients with ankle osteoarthritis. JAMA 2021,326(16),1595-1605","journal-title":"JAMA"},{"key":"ref=25","first-page":"232","volume":"17","author":"Saif D.S.","year":"2021","unstructured":"Saif D.S.; Hegazy N.N.; Zahran E.S.; Evaluating the efficacy of intra-articular injections of platelet rich plasma (PRP) in rheumatoid arthritis patients and its impact on inflammatory cytokines, disease activity and quality of life. Curr Rheumatol Rev 2021,17(2),232-241","journal-title":"Curr Rheumatol Rev"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"e19629","DOI":"10.7759\/cureus.19629","volume":"13","author":"Shively D.","year":"2021","unstructured":"Shively D.; Amin N.; Platelet-rich plasma for rheumatoid arthritis: A case series. Cureus 2021,13(11),e19629","journal-title":"Cureus"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"8761485","DOI":"10.1155\/2020\/8761485","volume":"2020","author":"Badsha H.","year":"2020","unstructured":"Badsha H.; Harifi G.; Murrell W.D.; Platelet rich plasma for treatment of rheumatoid arthritis: Case series and review of literature. Case Rep Rheumatol 2020,2020,8761485","journal-title":"Case Rep Rheumatol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s13287-017-0690-3","volume":"8","author":"Virz\u00ec F.","year":"2017","unstructured":"Virz\u00ec F.; Bianca P.; Giammona A.; Combined platelet-rich plasma and lipofilling treatment provides great improvement in facial skin-induced lesion regeneration for scleroderma patients. Stem Cell Res Ther 2017,8(1),236","journal-title":"Stem Cell Res Ther"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1136\/bjophthalmol-2018-312072","volume":"103","author":"Avila M.Y.","year":"2019","unstructured":"Avila M.Y.; Igua A.M.; Mora A.M.; Randomised, prospective clinical trial of platelet-rich plasma injection in the management of severe dry eye. Br J Ophthalmol 2019,103(5),648-653","journal-title":"Br J Ophthalmol"},{"key":"ref=30","first-page":"63","volume":"30","author":"Bottegoni C.","year":"2016","unstructured":"Bottegoni C.; Farinelli L.; Aquili A.; Chiurazzi E.; Gigante A.; Homologous platelet-rich plasma for the treatment of knee involvement in primary Sj\u00f6gren\u2019s syndrome. J Biol Regul Homeost Agents 2016,30(4),63-67","journal-title":"J Biol Regul Homeost Agents"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"103157","DOI":"10.1016\/j.transci.2021.103157","volume":"60","author":"Yi Z.","year":"2021","unstructured":"Yi Z.; Song N.; Chen Z.; Fan Y.; Liu Y.; Zhang B.; Autologous platelet-rich plasma in the treatment of refractory wounds in cutaneous leukocytoclastic vasculitis complicated with hypertension (grade 2 moderate risk): A case report. Transfus Apheresis Sci 2021,60(4),103157","journal-title":"Transfus Apheresis Sci"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1111\/1756-185X.12914","volume":"19","author":"Sriram S.","year":"2016","unstructured":"Sriram S.; Sankaralingam R.; Mani M.; Tamilselvam T.N.; Autologous platelet rich plasma in the management of non-healing vasculitic ulcers. Int J Rheum Dis 2016,19(12),1331-1336","journal-title":"Int J Rheum Dis"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.reth.2021.08.010","volume":"18","author":"Huber S.C.","year":"2021","unstructured":"Huber S.C.; de Lima M.S.A.; Sachetto Z.; Santos D.L.J.F.; Annichino-Bizzacchi J.M.; Characterization of autologous platelet rich plasma (PRP) and its biological effects in patients with Beh\u00e7et\u2019s Disease. Regen Ther 2021,18,339-346","journal-title":"Regen Ther"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"239","DOI":"10.5021\/ad.2017.29.2.239","volume":"29","author":"Serizawa N.","year":"2017","unstructured":"Serizawa N.; Funasaka Y.; Goto H.; Platelet-rich plasma injection and cutaneous sarcoidal granulomas. Ann Dermatol 2017,29(2),239-241","journal-title":"Ann Dermatol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.jdcr.2020.02.009","volume":"6","author":"Izhakoff N.","year":"2020","unstructured":"Izhakoff N.; Ojong O.; Ilyas M.; Platelet-rich plasma injections and the development of cutaneous sarcoid lesions: A case report. JAAD Case Rep 2020,6(4),348-350","journal-title":"JAAD Case Rep"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"106","DOI":"10.29021\/2688-9560.100006","volume":"1","author":"Tsai J.","year":"2017","unstructured":"Tsai J.; Flare of gout from injection of platelet-rich plasma. Acad Orthop Res Rheum 2017,1,106","journal-title":"Acad Orthop Res Rheum"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1002\/pmrj.12708","volume":"14","author":"Schroeder A.N.","year":"2022","unstructured":"Schroeder A.N.; Johnson S.E.; Sellon J.L.; Pseudogout flare after platelet\u2010rich plasma injection: A case series. PM R 2022,14(10),1301-1302","journal-title":"PM R"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"309","DOI":"10.36849\/JDD.5933","volume":"21","author":"Polster H.","year":"2022","unstructured":"Polster H.; Kagha K.; Luke J.; Platelet rich plasma for the treatment of scarring alopecia due to discoid lupus erythematosus. J Drugs Dermatol 2022,21(3),309-310","journal-title":"J Drugs Dermatol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1093\/pm\/pnaa170","volume":"21","author":"Burnham T.","year":"2020","unstructured":"Burnham T.; Sampson J.; Speckman R.A.; Conger A.; Cushman D.M.; McCormick Z.L.; The effectiveness of platelet-rich plasma injection for the treatment of suspected sacroiliac joint complex pain; a systematic review. Pain Med 2020,21(10),2518-2528","journal-title":"Pain Med"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1093\/pm\/pnab332","volume":"23","author":"Chen A.S.","year":"2021","unstructured":"Chen A.S.; Solberg J.; Smith C.; Intra-articular platelet rich plasma vs corticosteroid injections for sacroiliac joint pain: A double-blinded, randomized clinical trial. Pain Med 2021,23(7),1266-1271","journal-title":"Pain Med"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3233\/BMR-160734","volume":"30","author":"Ko G.D.","year":"2017","unstructured":"Ko G.D.; Mindra S.; Lawson G.E.; Whitmore S.; Arseneau L.; Case series of ultrasound-guided platelet-rich plasma injections for sacroiliac joint dysfunction. J Back Musculoskeletal Rehabil 2017,30(2),363-370","journal-title":"J Back Musculoskeletal Rehabil"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"511","DOI":"10.3233\/BMR-181366","volume":"32","author":"Mohi Eldin M.","year":"2019","unstructured":"Mohi Eldin M.; Sorour O.O.; Hassan A.S.A.; Baraka M.; Ahmed M.F.; Percutaneous injection of autologous platelet-rich fibrin versus platelet-rich plasma in sacroiliac joint dysfunction: An applied comparative study. J Back Musculoskeletal Rehabil 2019,32(3),511-518","journal-title":"J Back Musculoskeletal Rehabil"},{"key":"ref=43","first-page":"515","volume":"21","author":"Sanapati J.","year":"2018","unstructured":"Sanapati J.; Manchikanti L.; Atluri S.; Do regenerative medicine therapies provide long-term relief in chronic low back pain: A systematic review and metaanalysis. Pain Physician 2018,21(6),515-540","journal-title":"Pain Physician"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1111\/papr.12526","volume":"17","author":"Singla V.","year":"2017","unstructured":"Singla V.; Batra Y.K.; Bharti N.; Goni V.G.; Marwaha N.; Steroid vs. Platelet-rich plasma in ultrasound-guided sacroiliac joint injection for chronic low back pain. Pain Pract 2017,17(6),782-791","journal-title":"Pain Pract"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1097\/PHM.0000000000001389","volume":"99","author":"Wallace P.","year":"2020","unstructured":"Wallace P.; Bezjian W.L.; Tamura S.; Prochnio K.; Morgan K.; Hemler D.; Effectiveness of ultrasound-guided platelet-rich plasma injections in relieving sacroiliac joint dysfunction. Am J Phys Med Rehabil 2020,99(8),689-693","journal-title":"Am J Phys Med Rehabil"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1111\/papr.12544","volume":"17","author":"Wu J.","year":"2017","unstructured":"Wu J.; Zhou J.; Liu C.; A prospective study comparing platelet-rich plasma and local anesthetic (LA)\/Corticosteroid in intra-articular injection for the treatment of lumbar facet joint syndrome. Pain Pract 2017,17(7),914-924","journal-title":"Pain Pract"},{"key":"ref=47","first-page":"28","volume":"13","author":"Lin M.Y.","year":"2020","unstructured":"Lin M.Y.; Lin C.S.; Hu S.; Chung W.H.; Progress in the use of platelet-rich plasma in aesthetic and medical dermatology. J Clin Aesthet Dermatol 2020,13(8),28-35","journal-title":"J Clin Aesthet Dermatol"},{"key":"ref=48","first-page":"44","volume":"14","author":"White C.","year":"2021","unstructured":"White C.; Brahs A.; Dorton D.; Witfill K.; Platelet-rich plasma: A comprehensive review of emerging applications in medical and aesthetic dermatology. J Clin Aesthet Dermatol 2021,14(11),44-57","journal-title":"J Clin Aesthet Dermatol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"e18472","DOI":"10.7759\/cureus.18472","volume":"13","author":"Kauhl W.","year":"2021","unstructured":"Kauhl W.; Pototschnig H.; Paasch U.; Can platelet-rich plasma reduce the burden of inflammatory skin diseases such as psoriasis and atopic dermatitis? Cureus 2021,13(10),e18472","journal-title":"Cureus"}],"container-title":["Current Rheumatology Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573397119666230420112017","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/216137\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573397119666230420112017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T11:33:10Z","timestamp":1695123190000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/216137\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,3]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573397119666230420112017","relation":{},"ISSN":["1573-3971"],"issn-type":[{"value":"1573-3971","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-09-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-23","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}